Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

4.51
Delayed Data
As of Feb 17
 +0.28 / +6.62%
Today’s Change
2.65
Today|||52-Week Range
7.49
+9.47%
Year-to-Date
Insiders Roundup: Facebook, Twitter, Kellogg
Feb 17 / GuruFocus News - Paid Partner Content
3 Growth Stocks That Could Double
Feb 08 / MotleyFool.com - Paid Partner Content
Why Agenus Stock Is Surging Today
Feb 14 / MotleyFool.com - Paid Partner Content
Better Buy: Agenus Inc. vs. Alnylam Pharmaceuticals, Inc.
Feb 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.23
Today’s open4.23
Day’s range4.21 - 4.54
Volume2,131,619
Average volume (3 months)1,258,116
Market cap$392.4M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-30.09%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
MRUSMerus NV+0.22+0.88%
XBITXBiotech Inc+0.24+2.00%
MCRBSeres Therapeutics I...-0.08-0.83%
RXDXIgnyta Inc+0.05+0.52%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
VP-Finance &
Principal Accounting Officer
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts


Search for Jobs